Aidite (Qinhuangdao) Technology Co., Ltd.

301580 · SHE · Healthcare / Medical Instruments & Supplies

39.23CNY-0.93 (-2.32%)

Price History

Full chart

Market Stats

Previous Close40.16

Open40.38

Day Range39.02 – 40.69

52-Week Range29.41 – 87.98

Volume3.00M

Market Cap5.34B

P/E (TTM)35.79

Forward P/E0.00

EPS1.40

Dividend Yield0.92%

Beta0.93

50-Day Avg53.46

200-Day Avg49.53

About

Aidite (Qinhuangdao) Technology Co., Ltd. is a research and development firm of zirconia materials, dental materials, related consumables, and equipment for the dental industry in China. It offers ceramic denture zirconia repair materials, glass ceramics, elastic ceramics, resin materials, zirconia treatment agents, dental grinding and polishing burs, and dental five-axis cutting machines. The company also develops chairside restoration systems, invisible orthodontic solutions, and digital implant systems, and supplies dental implants, implant toolkits, and digital impression tools; and manufactures and sells oral hygiene products. In addition, the company offers intraoral scanners, dental cutting and sintering equipment, 3D printers, and related digital dental solutions. The company was founded in 2007 and is based in Qinhuangdao, China.

Company Details

SectorHealthcare
IndustryMedical Instruments & Supplies
CEOMr. Hongwen Li
Employees923
HeadquartersNo. 9, Dushan Road, Qinhuangdao, China, 066010, China
Websitehttps://www.aidite.com

Leadership

Mr. Hongwen LiChairman of the Board & GM · b. 1971
Mr. Xiangqian KongChief Financial Officer · b. 1973
Ms. Yu GaoDeputy GM & Board Secretary · b. 1988
Mr. Sheng Tang ZhangDeputy GM & Director · b. 1969
Mr. Wan Dong XieDeputy General Manager · b. 1970

Financials

Income Statement

Currency: CNY	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	57.71M	80.49M	107.70M	154.28M	212.56M	299.16M	361.63M	545.28M	602.73M	780.38M	888.17M	1.03B
Growth (%)	-	+39.49%	+33.79%	+43.25%	+37.78%	+40.74%	+20.88%	+50.78%	+10.54%	+29.47%	+13.81%	+16.51%
Cost of Revenue	21.85M	29.00M	44.24M	71.17M	94.97M	147.72M	209.01M	340.98M	331.40M	397.55M	419.66M	490.97M
Gross Profit	35.86M	51.50M	63.46M	83.10M	117.59M	151.45M	152.62M	204.31M	271.33M	382.83M	468.50M	543.81M
Gross Margin	62.14%	63.98%	58.93%	53.87%	55.32%	50.62%	42.20%	37.47%	45.02%	49.06%	52.75%	52.55%
Operating Expense	12.97M	22.09M	35.24M	45.43M	62.62M	93.97M	100.44M	140.67M	137.95M	211.60M	294.43M	357.02M
Operating Income	22.89M	29.41M	28.22M	37.67M	54.97M	57.48M	52.18M	63.64M	133.38M	171.23M	174.08M	186.78M
Operating Margin	39.67%	36.53%	26.20%	24.42%	25.86%	19.21%	14.43%	11.67%	22.13%	21.94%	19.60%	18.05%
EBITDA	23.65M	30.17M	31.17M	42.04M	57.78M	61.01M	57.08M	71.85M	140.80M	186.79M	198.34M	257.19M
EBITDA Margin	40.98%	37.48%	28.94%	27.25%	27.18%	20.39%	15.78%	13.18%	23.36%	23.94%	22.33%	24.85%
Net Income	17.73M	25.42M	25.31M	33.75M	47.37M	48.58M	44.62M	55.34M	115.80M	146.96M	150.49M	196.22M
Net Income Margin	30.73%	31.58%	23.51%	21.88%	22.29%	16.24%	12.34%	10.15%	19.21%	18.83%	16.94%	18.96%
R&D	-	4.01M	4.65M	6.63M	7.26M	11.66M	12.28M	20.70M	27.90M	40.07M	47.36M	73.59M
R&D as % of Total Revenue	-	4.98%	4.32%	4.30%	3.41%	3.90%	3.40%	3.80%	4.63%	5.13%	5.33%	7.11%
Interest Expense	-	-	-	-	124.22K	256.06K	1.74M	2.36M	1.49M	2.33M	2.75M	467.10K
Interest Expense % of Total Revenue	-	-	-	-	0.06%	0.09%	0.48%	0.43%	0.25%	0.30%	0.31%	0.05%

Balance Sheet

Currency: CNY	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	-	-	-	-	-	326.13M	432.14M	915.13M	1.12B	1.29B	2.29B	2.46B
Total Liabilities	-	-	-	-	-	120.39M	182.00M	132.96M	201.67M	212.20M	245.32M	312.78M
Total Equity	-	-	-	-	-	205.08M	249.67M	781.59M	911.36M	1.07B	1.99B	2.14B
Cash	-	-	-	-	-	36.13M	47.30M	160.61M	257.18M	558.16M	694.35M	249.02M
Total Debt	-	-	-	-	-	803.25K	32.49M	6.08M	44.35M	957.50K	4.75M	-
Net Debt	-	-	-	-	-	-35.33M	-14.82M	-154.53M	-212.84M	-556.76M	-689.61M	-

Cash Flow

Currency: CNY	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	18.19M	25.77M	32.24M	223.86M	140.09M	150.10M	273.66M
Investing Cash Flow	-33.47M	-15.17M	-347.93M	-139.70M	152.87M	-783.91M	-
Financing Cash Flow	-21.67M	10.62M	430.02M	-1.08M	-1.07M	768.47M	-
Capital Expenditure	18.72M	9.48M	22.38M	44.48M	33.20M	84.42M	68.78M
Free Cash Flow	-528.75K	16.29M	9.86M	179.38M	106.89M	65.68M	204.88M
Dividends Paid	40.00M	17.57M	1.05M	-	-	-	49.50M
FCF to OCF	-2.91%	63.21%	30.58%	80.13%	76.30%	43.76%	74.87%
Dividend Paid to FCF	-7564.97%	107.87%	10.60%	-	-	-	24.16%

Earnings

Report Date	Jun 30, 2024	Sep 30, 2024	Dec 31, 2024	Mar 31, 2025	Jun 30, 2025	Sep 30, 2025	Dec 31, 2025	Mar 31, 2026	Jun 30, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-
EPS Actual	0.36	0.23	0.28	0.21	0.41	0.33	0.37	0.26	0.44
Surprise	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap5.34B

Enterprise Value7.18B

Trailing P/E35.79

Forward P/E0.00

Price / Sales6.61

Price / Book3.92

EPS1.40

Book Value14.67

Revenue (TTM)1.13B

Gross Profit (TTM)594.17M

EBITDA242.69M

Profit Margin18.46%

Operating Margin19.97%

Return on Equity9.88%

Return on Assets5.32%

Shares Outstanding106.56M

Shares Float141.73M

Beta0.93

Dividend Yield0.92%

Dividend Rate0.46

Payout Ratio32.89%

Dividends

20261×

0.46Jun 10, 2026

20251×

0.33Jun 10, 2025

Stock Splits

Jun 10, 20261.4:1
Jun 10, 20251.4:1